Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, et al. Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clin Cancer Res. 2023;29(15):2933-2943.

Camacho A, Salah F, Bay CP, Waring J, Umeton R, Hirsch MS, et al. PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection. BJUI Compass. 2023;4(4):473-481.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076.

Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, et al. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol. 2023;12(1):71.

Tylawsky DE, Kiguchi H, Vaynshteyn J, Gerwin J, Shah J, Islam T, et al. P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis. Nat Mater. 2023;22(3):391-399.

Chen R, Chen D, Ong S, Lo D, DeSimone RA, Cushing MM, et al. Visualization dashboard for blood product inventory management. Transfusion. 2023;63(5):906-907.

SahBandar IN, Sy CB, van den Akker T, Kim D, Geyer JT, Chadburn A, et al. Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib. Pathobiology. 2023;90(5):356-364.

Boyraz B, Watkins JC, Young RH, Oliva E. Uterine Tumors Resembling Ovarian Sex Cord Tumors: A Clinicopathologic Study of 75 Cases Emphasizing Features Predicting Adverse Outcome and Differential Diagnosis. Am J Surg Pathol. 2023;47(2):234-247.

Halabi KC, Ross B, Acker KP, Cannon J-, Messina M, Mangino D, et al. Successful diagnostic stewardship for Clostridioides difficile testing in pediatrics. Infect Control Hosp Epidemiol. 2023;44(2):186-190.

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.